![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 06, 2021 11:25:42 AM
And what International Pharmas are testing in Russia:
1. Merck(USA) 4 studies 500 subjects
2. Novartis(Switz.) 4 studies 77 subjects
3. Interun Therapeutics (Ireland) 3 studies 466 subjects
4.Acadia Pharm. (USA) 3 studies 158 subjects
5.Minerva Pharm.(Greece) 2 studies 380 subjects
6.Rompharm (Romania) 2 studies subjects 330
7.Sentis Pharma (India) 2 studies subjects 264
8.Janssen(J&J) 2 studies subjects 160
9.AstraZenica(UK-Swedish) 2 studies subjects 128
10.Novo Nordisc(Denmark) 2 studies subjects 118
https://across.global/wp-content/uploads/2020/06/Synergy_Orange_Paper_Russia_2019Q1.pdf
Their costs of running trials are significantly cheaper than conducting them in the USA and the EU countries. Putin is ruthless, but he is a very smart man. He would not jeopardize the fledgling Clinical Trials industry that would become a major player on the world stage if he stepped in prematurely. He will wait with the rest of us for the proper protocols of releasing trial data. Additionally, the FDA and Europe's equivalent are on site in Russia overseeing the trials of American Pharmas. The FDA's oversight and the EU equivalent monitoring is what has given Russia the accolades and reason that worldwide Pharmas trust their Clinical Trial System. But that's just my opinion. IMO it was genius that Leo had the insight and foresight to utilize the Russian Clinical Trials system.
And to refute the argument that their vaccine (Sputnik) that Russia administered for its people is lacking efficacy or failed efficacy proves nothing. Their vaccine most likely went through a complete different trial scrutiny from the Clinical Trial system in place and Putin most likely had input on their vaccine. The drugs that US & EU Pharmas go through in Russia and the on site oversight that the FDA requires for verification of the proper protocols for phase 1,2,3 went through a much more vigorous protocols with international oversight at the venue sites where drugs were given for the different phase studies.
https://credevo.com/articles/2018/07/30/russia-clinical-trial-regulatory-process/
And it will be the success in Russia that will protect IPIX and B from being buried by Big Pharma and lobbyists here from reaching it’s true capabilities. BP can’t keep that enigmatic cat in the bag for much longer. IPIX will shine and prosper for all us longs and more importantly will save millions of lives from suffering and deaths to individuals and their families. For me financial remuneration will just be the icing on the cake. I welcome intelligent and thoughtful discourse.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM